CYANOCOBALAMIN


Trade Names	BERUBIGEN BETALIN 12 CALOMIST COBAVITE CYANOCOBALAMIN DODEX NASCOBAL REDISOL RUBIVITE RUBRAMIN PC RUVITE VI-TWEL VIBISONE
Synonyms	Antipernicin Behepan Berubigen Betalin 12 Calomist Cobavite Cyanocobalamin Cyanocobalaminum Cyanocobalmin Cyanovit-b12 Cycobemin Cytacon Cytamen Dodecavite Dodex NSC-80365 Nascobal Normocytin Plecyamin Redisol Rubivamine Rubivite Rubramin Rubramin pc Ruvite Vi-twel Vibalt Vibisone Vitamin B 12 Vitamin b 12 Vitamin b(bdi1)(bdi2) Vitamin b-12 Vitamin b12 Vitamin b12 (as cyanocobalamin ) Vitamin b12 nos
Status
Molecule Category	Free-form
ATC	B03BA01
UNII	P6YC3EG204


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C63H89CoN14O14P
Molecular Weight	1356.4
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Bioactivity

Mechanism of Action	Action	Reference
Supplement	None	DailyMed

Cross References

Resources	Reference
ChEMBL	CHEMBL2110563
FDA SRS	P6YC3EG204
PubChem	24892734

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).